Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StopPRE: Aspirin Discontinuation in High-Risk Pregnancy
NCT03741179Phase 3Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Aug 2019
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in preeclampsia, sponsored by Vall d'Hebron Research Institute. Started Aug 2019; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT03741179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03741179.